Does PAROXETINE Cause Lipodystrophy acquired? 5 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Lipodystrophy acquired have been filed in association with PAROXETINE (Paroxetine). This represents 0.0% of all adverse event reports for PAROXETINE.
5
Reports of Lipodystrophy acquired with PAROXETINE
0.0%
of all PAROXETINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Lipodystrophy acquired From PAROXETINE?
Of the 5 reports.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAROXETINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PAROXETINE Cause?
Foetal exposure during pregnancy (1,894)
Drug ineffective (1,457)
Toxicity to various agents (1,407)
Drug abuse (1,214)
Anxiety (1,201)
Nausea (1,063)
Suicidal ideation (999)
Drug interaction (991)
Confusional state (975)
Dizziness (937)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
Which PAROXETINE Alternatives Have Lower Lipodystrophy acquired Risk?
PAROXETINE vs PAROXETINE\PAROXETINE
PAROXETINE vs PAROXETINE\PAROXETINE ANHYDROUS
PAROXETINE vs PASIREOTIDE
PAROXETINE vs PASIREOTIDE DIASPARTATE
PAROXETINE vs PATIROMER